
Life sciences doesn’t have a data problem. It has a making-sense-of-the-data problem.In this episode of Fractals: Life Science Conversations, Jo Halliday, CEO and Founder of Talking Medicines, joins host Colin Miller to explore how AI, natural language processing, and real-world signals can help life science organizations better understand what patients and healthcare professionals are actually saying—and turn those insights into better decisions.From the episode:Why unstructured healthcare conversations can reveal insights traditional datasets missHow Talking Medicines evolved from collecting first-party patient data to analyzing signals across multiple sourcesWhat rapidly changing GLP-1 conversations tell us about increasingly informed and empowered patientsHow message resonance and behavioral trends can help pharma determine whether its communications are actually moving the needleWhy the future of AI in life sciences will be less about the technology itself—and more about the questions it can help answer
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Beyond the Snapshot: Imaging Biology in Motion with Roughan Sheedy & Beth Fisher

Beyond Pain Management: A One Medicine Approach to Osteoarthritis with Guests Graham Lumsden and Jonathan Larkin

From Simulation to Scale: Rethinking Pharmaceutical Coating with Guest Dr. Michael Choi

From Baby Feeding to Better Outcomes: Building Virtual, Preventive Maternal Care with Guest Cory Wyman
Free AI-powered recaps of Fractals: Life Science Conversations and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.